Live Better
- Product NDC
- 51143-027
- 11-digit product format
- 511430027
- Labeler code
- 51143
- Product ID
- 51143-027_39fcb3d5-411b-3448-e063-6394a90aa254
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Bacitracin Zinc, Neomycin Sulfate, Polymyxin B Sulfate, and Pramoxine Hydrochloride
- Dosage form
- OINTMENT
- Route
- TOPICAL
- Labeler
- The Great Atlantic & Pacific Tea Company
- Application
- M004
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2012-03-31
- Substance
- BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE; PRAMOXINE HYDROCHLORIDE
- Active strength
- 500; 3.5; 10000; 10 [iU]/g; mg/g; [iU]/g; mg/g
- Pharmacologic classes
- Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Package NDC | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|
| 2024-11-09 02:27 UTC · source 2024-11-08 | excluded product | product | ad56d346431e… | cc804d4bbf1e… | |
| 2024-11-09 02:27 UTC · source 2024-11-08 | excluded package | package | 51143-027-02 | ad56d346431e… | cc804d4bbf1e… |
| 2024-10-04 04:10 UTC · source 2024-10-03 | excluded product | product | 367a005e9d99… | 383a685ebd0f… | |
| 2024-10-04 04:10 UTC · source 2024-10-03 | excluded package | package | 51143-027-02 | 367a005e9d99… | 383a685ebd0f… |
| 2024-07-10 04:00 UTC · source 2024-07-09 | excluded product | product | 557ba5c1ecfa… | 9c80585c8c6e… | |
| 2024-07-10 04:00 UTC · source 2024-07-09 | excluded package | package | 51143-027-02 | 557ba5c1ecfa… | 9c80585c8c6e… |
| 2024-05-28 21:12 UTC · source 2024-05-28 | excluded product | product | 8af77b9d5b6f… | d9bbb34c5368… | |
| 2024-05-28 21:12 UTC · source 2024-05-28 | excluded package | package | 51143-027-02 | 8af77b9d5b6f… | d9bbb34c5368… |
| 2024-05-15 03:39 UTC · source 2024-05-14 | excluded product | product | 834df4deac94… | adcc014656a3… | |
| 2024-05-15 03:39 UTC · source 2024-05-14 | excluded package | package | 51143-027-02 | 834df4deac94… | adcc014656a3… |
| 2024-03-11 06:39 UTC · source 2024-03-08 | excluded product | product | 1332a3947898… | d4bfe170f9cd… | |
| 2024-03-11 06:39 UTC · source 2024-03-08 | excluded package | package | 51143-027-02 | 1332a3947898… | d4bfe170f9cd… |
| 2022-08-30 03:57 UTC · source 2022-08-29 | excluded product | product | fb8cb913e6d1… | eb8c232b6be0… | |
| 2022-08-30 03:57 UTC · source 2022-08-29 | excluded package | package | 51143-027-02 | fb8cb913e6d1… | eb8c232b6be0… |
| 2022-04-09 23:13 UTC · source 2022-04-08 | excluded product | product | 86f5da6cb304… | a595104c45d7… | |
| 2022-04-09 23:13 UTC · source 2022-04-08 | excluded package | package | 51143-027-02 | 86f5da6cb304… | a595104c45d7… |
| 2022-04-04 05:40 UTC · source 2022-04-01 | excluded product | product | bd6a592717d7… | 303034d00443… | |
| 2022-04-04 05:40 UTC · source 2022-04-01 | excluded package | package | 51143-027-02 | bd6a592717d7… | 303034d00443… |
| 2021-12-27 23:28 UTC · source 2021-12-27 | excluded product | product | 8dfbde2a14a4… | c9ff85d89658… | |
| 2021-12-27 23:28 UTC · source 2021-12-27 | excluded package | package | 51143-027-02 | 8dfbde2a14a4… | c9ff85d89658… |
| 2020-12-18 03:04 UTC · source 2020-12-17 | excluded product | product | e2bbac7714bc… | 27bdfed8d636… | |
| 2020-12-18 03:04 UTC · source 2020-12-17 | excluded package | package | 51143-027-02 | e2bbac7714bc… | 27bdfed8d636… |
| 2020-06-10 20:45 UTC · source 2020-06-10 | excluded product | product | 9bebd1f3094a… | 5416666fcb17… | |
| 2020-06-10 20:45 UTC · source 2020-06-10 | excluded package | package | 51143-027-02 | 9bebd1f3094a… | 5416666fcb17… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Live Better
- Brand name suffix
- Triple Antibiotic plus Pain Relief
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| BACITRACIN ZINC | 500 [iU]/g |
| NEOMYCIN SULFATE | 3.5 mg/g |
| POLYMYXIN B SULFATE | 10000 [iU]/g |
| PRAMOXINE HYDROCHLORIDE | 10 mg/g |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 89Y4M234ES | Internal UNII lookup |
| 057Y626693 | Internal UNII lookup |
| 19371312D4 | Internal UNII lookup |
| 88AYB867L5 | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 1359350 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 7e7a0b4c-67a9-42f3-aacd-2606fde25090 | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 99e684e6-f435-feb8-d2bb-3a546f1cb768 | Product name | 2 | 20161117 |
| 25340b3b-3e4c-4ff8-abf6-3e62ec46bd0c | Product name | 1 | 20160603 |
| 2d352c73-a357-4193-a4de-dfdf9a2ac8e4 | Product name | 1 | 20150819 |
| 58f3f9b7-3b9b-a9c1-1c9f-18ac777192b8 | Product name | 1 | 20140508 |
| a7051cba-790b-a699-81f8-dbbbdbd9b5ac | Product name | 1 | 20140508 |
| b045ad64-0f28-9a02-2f9b-b34d94fb2278 | Product name | 1 | 20140508 |
| b6082387-f592-1148-0844-bd068fd213fb | Product name | 1 | 20140508 |
| da108d9e-edc8-17a3-8c28-3251c6a8accc | Product name | 1 | 20140508 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 51143-027-02 | 2024-11-08 | C162847 | 48780-1 | 9d75b9d0-8875-f424-e053-dadaa90a57ce | Live Better Triple Antibiotic plus Pain Relief |
| 51143-027-02 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-8875-f424-e053-dadaa90a57ce | Live Better Triple Antibiotic plus Pain Relief |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 51143-027-02 | Live BetterTriple Antibiotic plus Pain Relief | 1 in 1 CARTON | OINTMENT | 1 | 3 | |
| 51143-027-02 | Live BetterTriple Antibiotic plus Pain Relief | 28.4 g in 1 TUBE | OINTMENT | 28.4 | 3 |
DailyMed Socrata Ingredients#
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 51143-027 | LIVE BETTER TRIPLE ANTIBIOTIC PLUS PAIN RELIEF (BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE, AND PRAMOXINE HYDROCHLORIDE) OINTMENT [THE GREAT ATLANTIC & PACIFIC TEA COMPANY] | 2 | Current NDC, Legacy NDC, 2 package rows | 20241109_7e7a0b4c-67a9-42f3-aacd-2606fde25090.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Major Triple Antibiotic | BACITRACIN ZINC, NEOMYCIN, POLYMYXIN B SULFAT | Major Pharmaceuticals | a6cc3fbc-6302-4033-e053-2a95a90a19f0 | 2024-09-11 | Warnings | M004 |
| Leader Triple antibiotic | BACITRACIN,NEOMYCIN,POLYMXIN | Cardinal Health 110 dba LEADER | 2175e00a-bf85-3377-e063-6394a90a916f | 2024-09-06 | Warnings | M004 |
| Members Mark Triple Antibiotic | BACITRACIN ZINC, NEOMYCIN, POLYMYXIN B | Sam's West Inc | 200f4020-7699-4a9e-8fab-2d3df9e76836 | 2024-09-05 | Warnings | M004 |
| Leader Poly Bacitracin | BACITRACIN ZINC POLYMIXIN B SULFATE | Cardinal Health 110 dba LEADER | 20d7624f-cafa-25e1-e063-6394a90a4439 | 2024-08-29 | Warnings | M004 |
| triple antibiotic | BACITRACIN ZINC, NEOMYCIN, POLYMYXIN B | Meijer Distribution Inc | edcb423e-b5c2-4e26-8f7f-9b9ee575042c | 2024-08-19 | Warnings | M004 |
| Major Clotrimazole | CLOTRIMAZOLE | NuCare Pharmaceuticals,Inc. | 562dfc9f-1897-330a-e054-00144ff8d46c | 2024-08-14 | Warnings | M004 |
| Triple Antibiotic | BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE | Wildeman Business Group | 1f96450a-3bda-1f0a-e063-6294a90a514f | 2024-08-13 | Warnings | M004 |
| Triple Antibiotic | BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE | Provision Medical | bbf4b99c-9738-4855-82a6-f4e213924ec9 | 2024-08-09 | Warnings | M004 |
| Tetracyte Topical Tetracycline Hydrochloride | TETRACYCLINE HYDROCHLORIDE | VIADERMA DISTRIBUTION INC | 4ac5177d-bb67-45e6-adcf-44f0821746bd | 2024-08-01 | Warnings | M004 |
| Bacitracin | BACITRACIN | Padagis Israel Pharmaceuticals Ltd | bebbedf6-dd65-47a4-aa3e-ad197b3e05a1 | 2024-07-31 | Warnings | M004 |
| Bacitracin Zinc | BACITRACIN ZINC | Chain Drug Marketing Association Inc. | 1cd9ded3-068c-496e-e063-6394a90a6a0b | 2024-07-09 | Warnings | M004 |
| Anti-Itch with Aloe | HYDROCORTISONE 1% | Chain Drug Marketing Association Inc. | 1cbea7cd-03a0-1469-e063-6294a90a7cc1 | 2024-07-08 | Warnings | M004 |
| astonea First Aid | BACITRACIN ZINC | ASTONEA LABS PRIVATE LIMITED | de0b2e06-64bc-78f0-e053-2995a90a39a0 | 2024-06-25 | Warnings | M004 |
| Publix Bacitracin Zinc | BACITRACIN ZINC | PUBLIX SUPER MARKETS, INC. | 51f21123-7826-40c9-b2aa-b202125085e2 | 2024-06-17 | Warnings | M004 |
| Publix Triple Antibiotic | BACITRACIN ZINC 400 U, POLYMXYIN B SULFATE 5,000 U, NEOMYCIN SULFATE 3.5MG/G | PUBLIX SUPER MARKETS, INC. | 871fa43c-a1be-4c15-bbfa-a998a2d89d2e | 2024-06-17 | Warnings | M004 |
| Biofreeze Professional | MENTHOL, UNSPECIFIED FORM | NuCare Pharmaceuticals,Inc. | 66ff9726-20da-688a-e053-2a91aa0a59ac | 2024-06-06 | Warnings | M004 |
| QC Triple Antibiotic | BACITRACIN ZINC, NEOMYCIN SULFATE , POLYMYXIN B SULFATE. | Chain Drug Marketing Association | 1a1501a4-75b0-5900-e063-6394a90ad77a | 2024-06-04 | Warnings | M004 |
| Always Save Bacitracin Zinc | BACITRACIN ZINC | Trifecta Pharmaceuticals USA LLC | 1a00df31-a38a-fc82-e063-6394a90abbf3 | 2024-06-03 | Warnings | M004 |
| PENTREXCILINA TRIPLE ANTIBIOTIC PLUS PAIN RELIEF | BACITRACIN, NEOMYCIN, POLYMYXIN B, PRAMOXINE | OPMX LLC | 7c0d3cdf-af50-4a65-a01b-a33510feeb94 | 2024-05-17 | Warnings | M004 |
| PENIMIXCINA | BACITRACIN, NEOMYCIN SULFATE, POLYMIXIN B SULFATE, PRAMOXINE HYDROCHLORIDE | OPMX LLC | 92bcbc02-9683-4117-af2b-6d4687796f1f | 2024-05-17 | Warnings | M004 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 1359350 | bacitracin 500 UNT / neomycin 3.5 MG / polymyxin B 10,000 UNT / pramoxine HCl 10 MG in GM Topical Ointment | PSN | 7e7a0b4c-67a9-42f3-aacd-2606fde25090 | 3 |
| 1359350 | bacitracin 0.5 UNT/MG / neomycin 0.0035 MG/MG / polymyxin B 10 UNT/MG / pramoxine hydrochloride 0.01 MG/MG Topical Ointment | SCD | 7e7a0b4c-67a9-42f3-aacd-2606fde25090 | 3 |
| 1359350 | bacitracin 500 UNT / neomycin 3.5 MG / polymyxin B 10,000 UNT / pramoxine HCl 10 MG per GM Topical Ointment | SY | 7e7a0b4c-67a9-42f3-aacd-2606fde25090 | 3 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 51143-027-02 | 51143002702 | 1 TUBE in 1 CARTON (51143-027-02) / 28.4 g in 1 TUBE | 1 tube | 2012-03-31 | No | No | Current |